Medicinal Chemicals & Botanical Products·TAIPEI CITY, F5
Summary Financials
Revenue
$53,304
+0.0% YoY
FY 2024
Adj. EBITDA
-$390,631
-732.8% margin
FY 2024
Net Income
-$720,093
-1350.9% margin
FY 2024
EPS (Diluted)
-$0.01
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$23,104
FY 2024
Total Debt
$1.5M
FY 2024
Net Debt
$1.5M
FY 2024
Enterprise Value
—
Debt / EBITDA
-3.8x
FY 2024
EV / EBITDA
—
Employees
—
Cordyceps is a genus of ascomycete fungi that includes over 260 species worldwide, many of which are parasitic. Diverse variants of cordyceps have had more than 1,500 years of use in Chinese medicine.